FDA Commissioner Gottlieb Outlines Efforts to Advance Biotechnology Innovation

In a recent blog post from the FDA, Commissioner Scott Gottlieb acknowledges their role to help advance progress in biotechnology. Their approach will focus on three key areas: "First, advancing and protecting public and animal health by promoting innovation through an efficient and predictable science- and risk-based regulatory framework; second, strengthening public outreach and communication through strong, effective and transparent engagement with stakeholders; and third, increasing engagement with domestic and international partners through coordinated and collaborative actions to support regulatory alignment and efficiency."

We are excited to see FDA's continued interest in innovation as new technologies and research advance solutions for patients in need.

To read the full blog entry, follow the link below: https://blogs.fda.gov/fdavoice/index.php/2018/06/fdas-new-efforts-to-advance-biotechnology-innovation/